12/19
05:58 am
rna
Avidity Biosciences (NASDAQ:RNA) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
Low
Report
Avidity Biosciences (NASDAQ:RNA) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
12/19
05:58 am
rna
Avidity Biosciences (NASDAQ:RNA) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
Low
Report
Avidity Biosciences (NASDAQ:RNA) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
12/18
09:12 am
rna
Avidity Biosciences downgraded to In Line from Outperform at Evercore ISI
Low
Report
Avidity Biosciences downgraded to In Line from Outperform at Evercore ISI
12/18
09:12 am
rna
Avidity Biosciences downgraded to In Line from Outperform at Evercore ISI
Low
Report
Avidity Biosciences downgraded to In Line from Outperform at Evercore ISI
11/11
08:08 am
rna
Avidity Biosciences (NASDAQ:RNA) had its "neutral" rating reaffirmed by analysts at Chardan Capital. They now have a $72.00 price target on the stock.
Low
Report
Avidity Biosciences (NASDAQ:RNA) had its "neutral" rating reaffirmed by analysts at Chardan Capital. They now have a $72.00 price target on the stock.
11/11
07:58 am
rna
Rating for RNA
Low
Report
Rating for RNA